Engagements

ICC dispute over breach of supply

CRA was retained by claimant to provide expert reports and testimony in an ICC arbitration regarding damages pursuant to the failure of a supply agreement pertaining to a pharmaceutical product. CRA evaluated pricing, market trends, and profitability related to its damages opinion.

Related capabilities

Damages & Quantum
International Arbitration
Life Sciences Arbitration
Life Sciences Commercial Disputes
Life Sciences Litigation

Gregory K. Bell
Group Vice President and Life Sciences Practice Leader

Boston
+1-617-425-3357 gbell@crai.com
Archan Ruparel
he/him/his

Principal

Washington, DC
+1-202-662-3861 aruparel@crai.com

Antitrust & Competition
CRA News

Richard Bergin joins CRA's Finance Practice as Vice President

CRA is pleased to announce that Richard Bergin has joined the company’s Finance Practice as a vice president. “We are very pleased to welcome Richard to CRA,”...
Damages & Quantum
Articles

Trade Secrets Monetary Remedies Commentary

The rules for what money a successful trade secret claimant can recover are easy to state but often difficult to apply. The Sedona Conference’s Working Group...

Explore our thinking

ICC dispute over breach of supply

Meet our team

Related insights

Richard Bergin joins CRA's Finance Practice as Vice President

Trade Secrets Monetary Remedies Commentary